CEO, Board Member at IM Therapeutics - Woburn, MA, US
CMC and Regulatory Sr. Manager
Contact Kaitlyn Sullivan
Manager Operations
Contact Monika Witczak
VP, Immunology
Contact David Alleva
Vice President, Clinical Development
Contact Sarah Bird
Vice President, R&D
Contact Robert Perni
Clinical Trials Manager
Contact Janet Vogel
IM Therapeutics is building an HLA-directed platform for new therapies. We have demonstrated early effectiveness in type 1 diabetes and are building a pipeline of targeted therapies across autoimmune diseases.